Krebs Net Income Applicable To Common Shares from 2010 to 2024
| KREBSBIO | 104.14 8.79 7.78% |
Net Loss | First Reported 2016-12-31 | Previous Quarter -53.3 M | Current Value -35.7 M | Quarterly Volatility 27 M |
Check Krebs Biochemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Krebs Biochemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.5 M, Interest Expense of 41.6 M or Selling General Administrative of 5.7 M, as well as many indicators such as . Krebs financial statements analysis is a perfect complement when working with Krebs Biochemicals Valuation or Volatility modules.
Krebs | Net Income Applicable To Common Shares |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.